Inducto Steel Standalone September 2024 Net Sales at Rs 46.15 crore
Wed, Nov 27, 2024 1:03 PM

Inducto Steel Standalone September 2024 Net Sales at Rs 46.15 crore

A Flip by Avya Verma
Get it on Google Play
Reported Standalone quarterly numbers for Inducto Steel are: Net Sales at Rs 46.15 crore in September 2024 up 6.51% from Rs. 43.33 crore in September 2023. Quarterly Net Loss at Rs. 2.27 crore in September 2024 down 350.19% from Rs. 0.91 crore in September 2023. EBITDA stands negative at Rs. 3.06 crore in September 2024 down 242.33% from Rs. 2.15 crore in September 2023.

More great flips

Birlasoft Standalone September 2024 Net Sales at Rs 643.69 crore

Birlasoft Standalone September 2024 Net Sales at Rs 643.69 crore

Reported Standalone quarterly numbers for Birlasoft are: Net Sales at Rs 643.69 crore in September 2024 down 0.45% from Rs. 646.61 crore in September 2023. Quarterly Net Profit at Rs. 52.02 crore in September 2024 down 46.28% from Rs. 96.83 crore in September 2023. EBITDA stands at Rs. 88.07 crore in September 2024 down 38.6% from Rs. 143.44 crore in September 2023.

Open Flip
NTPC Green Energy's m-cap crosses Rs 1 lakh crore mark on debut

NTPC Green Energy's m-cap crosses Rs 1 lakh crore mark on debut

D-Street debutant NTPC Green Energy's market capitalisation breached the Rs 1 lakh crore mark on Wednesday as the stock shot up 10% following a lacklustre listing. NTPC's renewable energy arm was listed at Rs 111.50 on the NSE, a 3.2% premium over the issue price of Rs 108.The stock generated considerable interest on its opening day with over 26 crore shares changing hands around 1:15 pm.

Open Flip
Buy Aurobindo Pharma; target of Rs 1540: Geojit Financial Services

Buy Aurobindo Pharma; target of Rs 1540: Geojit Financial Services

Geojit Financial Services research report on Aurobindo Pharma: Aurobindo Pharma Ltd (ARBP) is a leading vertically-integrated pharmaceuticals company. Its business units comprise formulations, custom synthesis, peptides, aurozymes, research and development (R&D) and active pharmaceutical ingredients (API). In Q2FY25, consolidated revenue rose 8.0% YoY to Rs. 7,796cr.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon